345 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
strategy, and its long-term aspirational ESG goals. The company's evolved approach further integrates its ESG strategy and its business strategy … workforce representation and increased community engagement by the company's employees;
◦Advancing climate action goals and increasing the company's
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
with our company’s goals Executives are assessed on “Results” and demonstration of “Values” ― assessments are used as the basis for making individual … (Paid in shares) Rewards the achievement of financial goals and further aligns executive compensation with the interests of our shareholders
424B5
5n13tjxe as5
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
1go7hbg 6wj6
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.1
1fg85et1ojxwzlmd1zj3
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
1wcjxw9 e7yg9rg
25 Jan 24
Third party tender offer statement
8:13am
424B5
xu52qvl6m316szxhyrz
1 Nov 23
Prospectus supplement for primary offering
4:16pm
8-K/A
2gsz3
31 Oct 23
Departure of Directors or Certain Officers
4:30pm
424B3
nppi9igyp6wjtoa65sb
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
rh8mqn2 vtlx
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
t2o yssajej
10 Oct 23
Additional proxy materials by non-management
6:48am
8-K
EX-99.1
0tg4xew1
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am